Fulgent Genetics Inc (FLGT) Stock Price, Quote & News

Company Profile

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer serv...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 626 350 0537

Fax: 626 454 1667

Website: www.fulgentgenetics.com

Address:

4399 Santa Anita Avenue, El Monte, United States

Sexydream Jan. 30 at 7:54 PM

$FLGT 7 consecutive down days. You pumptards just don't learn! Daddy told you to short this junk at $60!!! Hahahahahahah

0 · Reply

Sexydream Jan. 28 at 7:46 PM

$FLGT @jf152 Taking bets. When will we see $25? I'd say by earnings it'll be below 25 for sure.

1 · Reply

Sexydream Jan. 27 at 6:51 PM

$FLGT @jf152 tired of losing yet? 🤣🤣🤣🤣 Told u to listen to daddy. Daddy never loses! You are an expert at bag holding and I commend you. Even if one tried, they wouldn't be able to pick a worse stock 🤡

1 · Reply

jf152 Jan. 21 at 10:03 PM

$FLGT

1 · Reply

Sexydream Jan. 20 at 5:48 PM

$FLGT I let the stock price do the talking. Don't need to yap yap gibberish nonsense out of bitterness from losing w this stock. That's the job of @jf152 Stock back to 27. Going lower. No momentum, breakout, nothing. Dead ass junk stock. I'm still short tho I covered a good chunk at 25 for 100% gain on my puts.

0 · Reply

ChloeRoss Jan. 19 at 6:51 PM

$FLGT Quiet accumulation, breakout above could fuel momentum to the upside

0 · Reply

TofuDofu Jan. 17 at 11:33 PM

$FLGT just came across this company. Seems like they have a lot of cash and the valuation doesnt make much sense. Market cap is almost same as cash, meaning the market values this business as zero. Am i missing something?

1 · Reply

Jimmyboy29 Jan. 16 at 8:49 PM

$FLGT the next one from the covid era that is surviving nice without it and is the next to squeeze like $MRNA imo

1 · Reply

jf152 Jan. 14 at 12:28 PM

$FLGT the stock is massively up and outperformimg the market by multiples. And this evil liar keeps citing a price during a short squeeze many many years that nobody here bought at...

1 · Reply

Sexydream Jan. 14 at 5:58 AM

$FLGT no point of keep repeating the same thing, so I'll do it one last time. THE STOCK IS 28 BUX. How pathetic of you to celebrate like it's gone to $100. Goes to show you how big loser yall are. Smhhhh Stock went from 189 to 28!! What are you idiots celebrating for???? Pathetic losers. @jf152

0 · Reply

Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock

Dec 22, 2025, 4:10 PM EST - 5 weeks ago

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

Nov 11, 2025, 9:04 AM EST - 2 months ago

Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 7, 2025, 4:05 PM EST - 3 months ago

Fulgent to Participate in Upcoming Conferences

Nov 7, 2025, 2:56 PM EST - 3 months ago

Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 7:05 AM EST - 3 months ago

Fulgent Reports Third Quarter 2025 Financial Results

Oct 20, 2025, 6:00 AM EDT - 3 months ago

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

Oct 16, 2025, 7:00 AM EDT - 3 months ago

Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025

Sep 8, 2025, 1:58 PM EDT - 5 months ago

Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)

Aug 1, 2025, 12:28 PM EDT - 6 months ago

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 7:00 AM EDT - 6 months ago

Fulgent Reports Second Quarter 2025 Financial Results

Jul 17, 2025, 7:00 AM EDT - 7 months ago

Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM

Jul 10, 2025, 4:05 PM EDT - 7 months ago

Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025

Jun 10, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out

Jun 9, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation

Jun 8, 2025, 10:00 AM EDT - 8 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 6, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Shareholders to Inquire about Securities Investigation

Jun 5, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Investors to Connect

Jun 4, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Stockholders to Inquire about Securities Investigation

Jun 3, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Investors to Learn More About the Investigation

Jun 2, 2025, 10:00 AM EDT - 8 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 30, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect

May 29, 2025, 10:00 AM EDT - 8 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 28, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Stockholders to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Investors to Inquire about Securities Investigation

May 24, 2025, 9:19 PM EDT - 8 months ago

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

May 19, 2025, 8:11 AM EDT - 9 months ago

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

May 2, 2025, 12:27 PM EDT - 9 months ago

Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript

May 2, 2025, 7:00 AM EDT - 9 months ago

Fulgent Reports First Quarter 2025 Financial Results

Apr 10, 2025, 4:05 PM EDT - 10 months ago

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

Apr 4, 2025, 2:30 PM EDT - 10 months ago

Stock Picks From Seeking Alpha's March 2025 New Analysts

AI ARGX CCL CEPU CF CROX CUK

Mar 20, 2025, 5:46 AM EDT - 11 months ago

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy

Feb 28, 2025, 11:57 AM EST - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript

Feb 28, 2025, 7:00 AM EST - 1 year ago

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 6, 2025, 4:05 PM EST - 1 year ago

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Feb 4, 2025, 4:00 PM EST - 1 year ago

Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics

Dec 24, 2024, 1:25 AM EST - 1 year ago

Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside

Nov 11, 2024, 2:07 AM EST - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:00 AM EST - 1 year ago

Fulgent Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Oct 17, 2024, 4:05 PM EDT - 1 year ago

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Sep 25, 2024, 11:32 AM EDT - 1 year ago

Fulgent Genetics: An NCAV Pick With Profit And Growth Potential

Sep 9, 2024, 12:05 PM EDT - 1 year ago

Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst

Aug 2, 2024, 10:24 AM EDT - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript

Aug 2, 2024, 7:00 AM EDT - 1 year ago

Fulgent Reports Second Quarter 2024 Financial Results

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024

Sexydream Jan. 30 at 7:54 PM

$FLGT 7 consecutive down days. You pumptards just don't learn! Daddy told you to short this junk at $60!!! Hahahahahahah

0 · Reply

Sexydream Jan. 28 at 7:46 PM

$FLGT @jf152 Taking bets. When will we see $25? I'd say by earnings it'll be below 25 for sure.

1 · Reply

Sexydream Jan. 27 at 6:51 PM

1 · Reply

jf152 Jan. 21 at 10:03 PM

$FLGT

1 · Reply

Sexydream Jan. 20 at 5:48 PM

0 · Reply

ChloeRoss Jan. 19 at 6:51 PM

$FLGT Quiet accumulation, breakout above could fuel momentum to the upside

0 · Reply

TofuDofu Jan. 17 at 11:33 PM

1 · Reply

Jimmyboy29 Jan. 16 at 8:49 PM

$FLGT the next one from the covid era that is surviving nice without it and is the next to squeeze like $MRNA imo

1 · Reply

jf152 Jan. 14 at 12:28 PM

$FLGT the stock is massively up and outperformimg the market by multiples. And this evil liar keeps citing a price during a short squeeze many many years that nobody here bought at...

1 · Reply

Sexydream Jan. 14 at 5:58 AM

0 · Reply

OfficialStocktwitsUser Jan. 13 at 11:26 PM

$FLGT RSI: 56.45, MACD: 0.1255 Vol: 0.87, MA20: 27.12, MA50: 27.41 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

jf152 Jan. 13 at 7:49 PM

So much truth! $FLGT

0 · Reply

jf152 Jan. 12 at 8:28 PM

$FLGT

0 · Reply

jf152 Jan. 11 at 9:28 PM

$FLGT When did any of this happen? Oh wait, it was AN INTENTIONAL LIE.

0 · Reply

jf152 Jan. 11 at 9:16 PM

$FLGT Whatever happened to this? An INTENTIONAL LIE.

0 · Reply

jf152 Jan. 11 at 9:15 PM

$FLGT Whatever happened to this? Oh wait. It was an INTENTIONAL LIE.

0 · Reply

jf152 Jan. 10 at 7:37 PM

Your reminder that @sexydream is intentionally trying to deceive people. $FLGT He's angry about his own foolish decisions. Fulgent is massively outperforming the market.

0 · Reply

jf152 Jan. 9 at 9:17 PM

$FLGT The spread between the Bid and Ask on this stock are silly. This is why it is subject to low volume price manipulation. Also, before @sexydream celebrates a 4 penny decline today, a reminder: Fulgent is up 6% YTD.

1 · Reply

pilobious Jan. 8 at 9:41 PM

$FLGT Whining Verbotten!

0 · Reply

jf152 Jan. 8 at 9:38 PM

$FLGT What kind of person celebrates a 12 cent decline on a stock that's way up on the week? A bad person who has lies to peddle.

0 · Reply

Sexydream Jan. 8 at 7:44 PM

$FLGT @jf152 @Bigcoog2020 smh....we gonna go thru this again? Stock up 1 day and you guys resurface only to go silent again after it drops another 20%. Haven't you learned by now? Stock is at 27. Calm your panties. You guys act like it's gone to 100. Smh..... It's at 27. Geezus. What a bunch of bag holding losers we got here.

1 · Reply

jf152 Jan. 7 at 9:01 PM

$FLGT Up over 6% percentage since this terrible advice. @sexydream is just a bad person. He intentionally lies.

0 · Reply

Market Cap	811.13M
Revenue (ttm)	283.47M
Net Income (ttm)	-42.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-15.07%
Debt to Equity Ratio	0.00

Volume	181,100
Avg Vol	218,798
Day's Range	N/A - N/A
Shares Out	30.91M
Stochastic %K	11%
Beta	0.63
Analysts	Strong Sell
Price Target	$33.67